Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janaki Narahari is active.

Publication


Featured researches published by Janaki Narahari.


Biochemistry | 2018

Characterization and Use of TurboLuc Luciferase as a Reporter for High-Throughput Assays

Douglas S. Auld; Janaki Narahari; Pei-i Ho; Dominick Casalena; Vy Nguyen; Evelina Cirbaite; Douglas Hughes; John W. Daly; Brian Webb

Luciferase-based reporter assays are powerful tools for monitoring gene expression in cells because of their ultrasensitive detection capacity and wide dynamic range. Here we describe the characterization and use of a luciferase reporter enzyme derived from the marine copepod Metridia luciferase family, referred to as TurboLuc luciferase (TurboLuc). To develop TurboLuc, the wild-type luciferase was modified to decrease its size, increase brightness, slow luminescent signal decay, and provide for efficient intracellular expression. To determine the enzyme susceptibility to compound inhibition and judge the suitability of using of TurboLuc as a reporter in screening assays, purified TurboLuc enzyme was screened for inhibitors using two different compound libraries. No inhibitors of this enzyme were identified in a library representative of typical diverse low molecular weight (LMW) compounds using a purified TurboLuc enzyme assay supporting that such libraries will show very low interference with this enzyme. We were able to identify a few inhibitors from a purified natural product library which can serve as useful tools to validate assays using TurboLuc. In addition to the inhibitor profile for TurboLuc we describe the use of this reporter in cells employing miniaturized assay volumes within 1536-well plates. TurboLuc luciferase is the smallest luciferase reporter enzyme described to date (16 kDa), shows bright luminescence and low interference by LMW compounds, and therefore should provide an ideal reporter in assays applied to high-throughput screening.


Cancer Research | 2012

Abstract 3207: Monitoring changes in NF-kB pathway regulation using highly sensitive multiplex bioluminescent reporter assays

Megan Dobbs; Douglas Hughes; Janaki Narahari; Jae Choi; Atul Deshpande; Brian Webb

Monitoring gene activation and repression in cellular signaling pathways requires specific tools. Reporter gene assays use a technique of attaching a genetic regulatory element, or promoter, to a gene encoding for a protein with enzymatic, chromophoric or fluorescent properties. Cloned into a plasmid vector, these sequences can be transfected or transduced into animal, plant or tissue culture cells. Reporter gene expression can be measured via bioluminescent, chemiluminescent or fluorescent output to quantify the element or protein activity in the pathway affecting the regulatory element. Bioluminescent output is formed through the catalysis of a substrate and the natural enzyme luciferase. Present in many terrestrial and marine metazoans, bioluminescence is a powerful instrument for mutational analysis of gene promoters, transcription factor dynamics, and protein-protein interactions. Our study confirmed the beneficial use of sensitive bioluminescent enzymes in reporter gene assays with wide dynamic ranges and flexibility in signal identification. Mutation of several of the luciferase genes resulted in spectral shifting and narrowing of the photon reaction products relative to the wavelength of the natural state. The mutations provide the ability to spectrally resolve the modified luciferases in a single reaction. In addition, multiplex assays relying on sequential addition of substrates can be achieved through manipulation of the enzyme-substrate reaction conditions. Marine copepod and ostracod luciferase enzymes are naturally secreted, and reporter assays using these genes can capture real-time or time course data by sampling the media of transfected cells or blood from transgenic animals and assaying for luciferase. The distinct advantage of these assays is that they are not destructive to the cells or animals. Our study used spectral separation using Gaussia/firefly and multiplex assays relying on sequential addition of substrates and Gaussia/Cypridina to monitor changes in NFkB activity in response to small-molecule agonists. Our results demonstrate the usefulness of dual-secreted luciferase assays for sensitive real-time monitoring of NFkB activity in media. Furthermore, these assays enable simultaneous detection of spectrally resolvable luciferases using filter-based detection. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3207. doi:1538-7445.AM2012-3207


ACS Chemical Biology | 2013

Reporter Enzyme Inhibitor Study To Aid Assembly of Orthogonal Reporter Gene Assays

Pei-i Ho; Kimberley Yue; Pramod Pandey; Lyne Breault; Fred Harbinski; Aaron J. McBride; Brian Webb; Janaki Narahari; Natasha Karassina; Keith V. Wood; Adam Hill; Douglas S. Auld


Journal of Immunology | 2007

Importance of siRNA negative control selection: Evaluation of non-specific protein knock-down by negative control siRNA

Yvonne B. Sullivan; Douglas Hughes; Janaki Narahari; Brian Webb


The FASEB Journal | 2008

Analysis of Signaling Pathways using Antibody Microarrays and RNA Interference

Janaki Narahari; Aric Morgan; Krishna Vattem; Yvonne B. Sullivan; Douglas Hughes; Eric Hommema; Greg Kilmer; Brian Webb


The FASEB Journal | 2009

Characterization of EGFR pathway using small molecule inhibitors and In-Cell ELISA technology

Janaki Narahari; Douglas Hughes; Brian Webb


The FASEB Journal | 2008

Validation of antibody specificity using RNA Interference

Yvonne B. Sullivan; Janaki Narahari; Douglas Hughes; Brian Webb


The FASEB Journal | 2007

Antibody microarray analysis of inflammatory mediator release by human leukemia T cells and human non-small cell lung cancer cells

Aric Morgan; Bradley Garcia; Aubrey Hargrave; Eric Hommema; Greg Kilmer; Janaki Narahari; Brian Webb; Rick Wiese


Archive | 2007

New Transcription Factor Activation Kits for High Content Screening and Cell Based Assays

Kay Opperman; Roberta Litavecz; Janaki Narahari; Richik N. Ghosh


Archive | 2007

Transfection of Cyclophilin B (CyPB) SiRNA and not p53 siRNA Reduces the Levels of Cyclophilin B Drug & Cell Type Characterization for Determining Levels of p53, Phospho-p53 & p21 Status

Krishna Vattem; Janaki Narahari; Richik N. Ghosh

Collaboration


Dive into the Janaki Narahari's collaboration.

Top Co-Authors

Avatar

Brian Webb

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar

Douglas Hughes

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric Hommema

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar

Greg Kilmer

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar

Krishna Vattem

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Douglas S. Auld

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge